Compare · 2 funds side by side · dividends reinvested

PJP and XBI

PJPInvesco×XBISPDR×

Versus in desk

Story of the two · Growth5Y$10,000 five years agoDividends reinvested · both on one scale$17,811PJP · best of the two

02 / 04

PJP and XBI, Ranked

Today

FundFeeYieldYTD1 year3 yrs · yr5 yrs · yrWorst dropVolatilityAssetsAvg rank

Invesco Pharmaceuticals ETFSectors · Health care0.58%0.86%+26.9%+37.1%+25.5%+12.2%−9.4%17.6%$579M1.5

State Street SPDR S&P Biotech ETFSectors · Health care0.35%0.34%+30.6%+45.4%+34.9%+5.5%−14.9%29.1%$10.6B1.5

Rank among the two1st → 2ndFee, drop and volatility: lower ranks higherAvg rank: mean of the 8 ranks · 1 is best

End-of-day Nov 4, 2026 · returns include dividends · since: PJP 2005 · XBI 2006

Head to Head

Swap sides Versus in desk

Head to Head

Invesco Pharmaceuticals ETF · $579M$17,811

PJP

XBI

State Street SPDR S&P Biotech ETF · $10.6B$13,100

$10,000 five years ago, dividends reinvested · they hold 11.4% in common

PJPMeasureXBI

+26.9%Year to dateJan 1 → Nov 4+30.6%

+37.1%1 yearTotal return+45.4%

+25.5%3 years · per year$10,000 became $19,752 · $24,560+34.9%

+12.2%5 years · per year$10,000 became $17,811 · $13,100+5.5%

0.58%Expense ratio$58 · $35 a year on $10k · lower is better0.35%

0.86%Trailing 12-mo yield$86 · $34 a year on $10k0.34%

−9.4%Worst dropSmaller is better−14.9%

17.6%VolatilityLower is calmer29.1%

PJPXBI Winner of the row, in its colourEach row: the bigger of the two fills its side

4–4Level

End-of-day Nov 4, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns

More Ways to See the Pairs

PJP vs XBI: Top 5 Holdings

Today

PJP

29.2%in top 5

XBI

in top 59.5%

PJPStockXBI

6.1%LLYnot top 5

6.1%GILDnot top 5

5.8%ABBVnot top 5

5.6%PFEnot top 5

5.6%AMGNnot top 5

not top 5MRNA2.5%

not top 5EXEL1.8%

not top 5REGN1.8%

not top 5HALO1.8%

not top 5UTHR1.7%

Held in common11.4%

End-of-day Nov 4, 2026 · share of each fund

PJP vs XBI Returns, Every Period

InvescoPJP

+12.2%

5 years, per year

XBISPDR

+5.5%

5 years, per year

PJPXBIFaded: behind in that period

1–3XBI wins

End-of-day Nov 4, 2026 · dividends in · faded = behind in that period

PJP vs XBI

YTD

InvescoPJP

+26.9%

XBISPDR

+30.6%

+26.9%Year to date+30.6%

−9.4%Worst drop · 1Y−14.9%

17.6%Volatility · 1Y29.1%

0.9%Yield0.3%

$579MAssets$10.6B

3–1PJP wins

End-of-day Nov 4, 2026 · smaller drop and lower volatility win

Cost, Income and Risk

Fees: PJP, XBI

Today

0.35%lowest, XBI

FundExpense ratioFee$10k

XBI0.35%$35

PJP0.58%$58

End-of-day Nov 4, 2026 · fee on $10,000 a year

Yields: PJP, XBI

0.86%highest, PJP

FundTrailing yieldYield$10k

PJP0.86%$86

XBI0.34%$34

End-of-day Nov 4, 2026 · trailing 12-month yield

Income After Fees on $10,000

$28most kept, PJP

PJP$86 − $58 = $28

XBI$34 − $35 = −$1

KeptFee

End-of-day Nov 4, 2026 · yield in dollars minus the fee

Overlap: PJP, XBI

Today

11.4%most shared, PJP and XBI

PJPXBI

PJP—11.4%

XBI11.4%—

End-of-day Nov 4, 2026 · share held in common · outlined: the pair in versus

Return vs Bumpiness: 2 ETFs

+45.4%XBI, at 29.1% volatility

PJPWorst drop−9.4%17.6% vol

XBIWorst drop−14.9%29.1% vol

End-of-day Nov 4, 2026 · up and left is better

Paid More vs Made More

YTD

PJPXBI

+26.9%Year to date+30.6%

0.9%Yield0.3%

+37.1%Past year+45.4%

0.58%Fee0.35%

3–1XBI wins

End-of-day Nov 4, 2026

Popular Pairs Near These Two

SCHD vs VIG

YTD

SchwabSCHD

+35.3%

VIGVanguard

+16.4%

+35.3%Year to date+16.4%

2.9%Yield1.4%

$123BAssets$109B

2–0SCHD wins

End-of-day Nov 4, 2026

JEPQ vs JEPI

YTD

J.P. MorganJEPQ

+8.5%

JEPIJ.P. Morgan

+8.8%

+8.5%Year to date+8.8%

12.2%Yield7.8%

$42.1BAssets$46.1B

1–1level

End-of-day Nov 4, 2026

SPYM vs SPY

YTD

SPDRSPYM

+13.4%

SPYSPDR

+13.3%

+13.4%Year to date+13.3%

1.0%Yield1.0%

$182BAssets$805B

1–0SPYM wins

End-of-day Nov 4, 2026